Respiratory tract infections and pneumonia.
作者信息
McChlery Susan, Ramage Gordon, Bagg Jeremy
出版信息
Periodontol 2000. 2009 Feb;49(1):151-65. doi: 10.1111/j.1600-0757.2008.00278.x.
Abstract
摘要
相似文献
1
Respiratory tract infections and pneumonia.
Periodontol 2000. 2009 Feb;49(1):151-65. doi: 10.1111/j.1600-0757.2008.00278.x.
2
Bacterial-viral interrelations in respiratory infections of children.
N Engl J Med. 1967 Sep 28;277(13):667-72. doi: 10.1056/NEJM196709282771301.
3
The respiratory tract and its infections.
Harv Health Lett. 2010 Feb;35(4):1-4.
4
[A clinical study of chronic lower respiratory infection with Haemophilus influenza by transtracheal aspiration].
Kansenshogaku Zasshi. 1996 Sep;70(9):947-54. doi: 10.11150/kansenshogakuzasshi1970.70.947.
5
Haemophilus influenzae as a respiratory pathogen.
Anglo Ger Med Rev. 1969 Oct;5:117-24.
6
Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections.
J Clin Virol. 2017 Jan;86:14-19. doi: 10.1016/j.jcv.2016.11.008. Epub 2016 Nov 22.
7
Etiological agents of lower respiratory tract infections in Japanese children.
In Vivo. 2004 Jan-Feb;18(1):67-71.
8
H5N1 Virus Attachment to Lower Respiratory Tract.
Science. 2006 Apr 21;312(5772):399. doi: 10.1126/science.1125548. Epub 2006 Mar 23.
9
Role of Hemophilus influenzae in pediatric respiratory infections.
Ann N Y Acad Sci. 1967 Sep 27;145(2):391-7. doi: 10.1111/j.1749-6632.1967.tb50237.x.
10
Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Am J Med. 2001 Dec 17;111 Suppl 9A:4S-12S; discussion 36S-38S. doi: 10.1016/s0002-9343(01)01025-7.
引用本文的文献
1
Integrated Microbiome Data Analysis Reveals Potential Pneumonia Microbial Biomarkers in ICU Patients: A Machine Learning Approach.
Curr Microbiol. 2025 Aug 30;82(10):483. doi: 10.1007/s00284-025-04464-y.
2
sp. nov., a novel pathogenic species isolated from tuberculous pleurisy patient.
Front Cell Infect Microbiol. 2025 Aug 7;15:1629703. doi: 10.3389/fcimb.2025.1629703. eCollection 2025.
3
Optimizing Photosensitizer Delivery for Effective Photodynamic Inactivation of Under Lung Surfactant Conditions.
Pathogens. 2025 Jun 21;14(7):618. doi: 10.3390/pathogens14070618.
4
Advances in gut-lung axis research: clinical perspectives on pneumonia prevention and treatment.
Front Immunol. 2025 Apr 22;16:1576141. doi: 10.3389/fimmu.2025.1576141. eCollection 2025.
5
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.
Mil Med Res. 2024 Dec 16;11(1):78. doi: 10.1186/s40779-024-00581-0.
6
Microbiota of Saliva: A Non-invasive Diagnostic Tool.
Indian J Microbiol. 2024 Jun;64(2):328-342. doi: 10.1007/s12088-024-01219-4. Epub 2024 Mar 4.
7
Synthesis and antibacterial activity of monocyclic 3-carboxamide tetramic acids.
Beilstein J Org Chem. 2013 Sep 19;9:1899-906. doi: 10.3762/bjoc.9.224. eCollection 2013.
8
Talking about colds and flu: the lay diagnosis of two common illnesses among older British people.
Soc Sci Med. 2011 Sep;73(6):922-8. doi: 10.1016/j.socscimed.2010.09.054. Epub 2010 Nov 24.
9
Bacterial and viral pathogens in saliva: disease relationship and infectious risk.
Periodontol 2000. 2011 Feb;55(1):48-69. doi: 10.1111/j.1600-0757.2010.00361.x.
10
Association of residential dampness and mold with respiratory tract infections and bronchitis: a meta-analysis.
Environ Health. 2010 Nov 15;9:72. doi: 10.1186/1476-069X-9-72.
本文引用的文献
1
The Significance of Pneumococcal Types.
J Hyg (Lond). 1928 Jan;27(2):113-59. doi: 10.1017/s0022172400031879.
2
The pathology of pulmonary disorders due to Aspergillus spp.
Arch Pathol Lab Med. 2008 Apr;132(4):606-14. doi: 10.5858/2008-132-606-TPOPDD.
3
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clin Infect Dis. 2008 Feb 1;46(3):327-60. doi: 10.1086/525258.
4
Salvage therapy for invasive aspergillosis.
J Antimicrob Chemother. 2008 Jan;61 Suppl 1:i41-4. doi: 10.1093/jac/dkm426.
5
[Lung cavities, mycetomas and hemoptysis].
Wien Med Wochenschr. 2007;157(19-20):466-72. doi: 10.1007/s10354-007-0460-4.
6
Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.
Antimicrob Agents Chemother. 2008 Feb;52(2):716-8. doi: 10.1128/AAC.00760-07. Epub 2007 Nov 5.
7
In the clinic. Influenza.
Ann Intern Med. 2007 Oct 2;147(7):ITC10-1-ITC10-16. doi: 10.7326/0003-4819-147-7-200710020-01010.
8
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.
Drugs. 2007;67(11):1567-601. doi: 10.2165/00003495-200767110-00004.
9
Preparing for a possible pandemic: influenza A/H5N1 vaccine development.
Curr Opin Pharmacol. 2007 Oct;7(5):484-90. doi: 10.1016/j.coph.2007.06.004. Epub 2007 Jul 17.
10
Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus.
Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):309-27. doi: 10.1016/j.cimid.2007.05.009. Epub 2007 Jul 19.
Zotero 插件